Kercheville Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,001
| Closed | -$549K | – | 107 |
|
|
2025
Q1 | $549K | Buy |
9,001
+5,305
| +144% | +$324K | 0.22% | 58 |
|
|
2024
Q4 | $209K | Buy |
+3,696
| New | +$209K | 0.08% | 82 |
|
|
2024
Q2 | – | Sell |
-3,778
| Closed | -$205K | – | 86 |
|
|
2024
Q1 | $205K | Buy |
+3,778
| New | +$205K | 0.1% | 75 |
|
|
2023
Q4 | – | Sell |
-9,354
| Closed | -$543K | – | 82 |
|
|
2023
Q3 | $543K | Sell |
9,354
-2,647
| -22% | -$154K | 0.34% | 42 |
|
|
2023
Q2 | $767K | Sell |
12,001
-365
| -3% | -$23.3K | 0.46% | 40 |
|
|
2023
Q1 | $857K | Sell |
12,366
-1,880
| -13% | -$130K | 0.59% | 38 |
|
|
2022
Q4 | $1.02M | Buy |
14,246
+4
| +0% | +$288 | 0.71% | 32 |
|
|
2022
Q3 | $1.01M | Sell |
14,242
-346
| -2% | -$24.6K | 1.03% | 29 |
|
|
2022
Q2 | $1.12M | Sell |
14,588
-10,480
| -42% | -$807K | 0.74% | 30 |
|
|
2022
Q1 | $1.83M | Buy |
25,068
+10,287
| +70% | +$751K | 0.87% | 27 |
|
|
2021
Q4 | $922K | Sell |
14,781
-870
| -6% | -$54.3K | 0.4% | 50 |
|
|
2021
Q3 | $926K | Sell |
15,651
-7,806
| -33% | -$462K | 0.44% | 54 |
|
|
2021
Q2 | $1.57M | Buy |
23,457
+258
| +1% | +$17.2K | 0.73% | 40 |
|
|
2021
Q1 | $1.46M | Sell |
23,199
-13,717
| -37% | -$863K | 0.73% | 41 |
|
|
2020
Q4 | $2.27M | Buy |
+36,916
| New | +$2.27M | 1.24% | 23 |
|